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ABSTRACT
The covalent addition of methylgroups to cytosine
has become the most intensively researched
epigenetic DNA marker. The vast majority of
technologies used for DNA methylation analysis
rely on a chemical reaction, the so-called
‘bisulfite treatment’, which introduces methylation-
dependent sequence changes through selective
chemical conversion of non-methylated cytosine
to uracil. After treatment, all non-methylated
cytosine bases are converted to uracil but all
methylated cytosine bases remain cytosine.
These methylation dependent C-to-T changes
can subsequently be studied using conventional
DNA analysis technologies.
The bisulfite conversion protocol is susceptible to
processing errors, and small deviation from the
protocol can result in failure of the treatment.
Several attempts have been made to simplify the
procedure and increase its robustness. Although
significant achievements in this area have been
made, bisulfite treatment remains the main source
of process variability in the analysis of DNA
methylation. This variability in particular impairs
assays, which strive for the quantitative assessment
of DNA methylation. Here we present basic mathe-
matical considerations, which should be taken
into account when analyzing DNA methylation.
We also introduce a PCR-based assay, which
allows ab initio assessment of the DNA quality
after bisulfite treatment and can help to prevent
inaccurate quantitative measurement resulting
from poor bisulfite treatment.
INTRODUCTION
Several bisulﬁte treatment protocols are available, and
most of them include mixing genomic DNA in a solution
containing 6M urea and 2M sodium meta-bisulﬁte.
The reaction is then incubated at pH 5.0 and 508C
for 5–16h. This chemical treatment introduces various
DNA strand breaks and results in highly fragmented
single-stranded DNA. Depurination has been identiﬁed
as the main cause of DNA fragmentation during bisulﬁte
treatment (1). It has been shown that degradation of
DNA aﬀects between 84–96% of the DNA (2). Various
attempts have been made to optimize bisulﬁte treatment
by balancing competing goals of maintaining complete
cytosine conversion and minimal DNA fragmentation
(1–4). Aggressive bisulﬁte treatment protocols (long
incubation, high temperatures, high molarity of bisulﬁte)
assure complete conversion of cytosine to uracil, but the
genomic DNA can be degraded to a degree that renders
PCR ampliﬁcation impossible. Less aggressive treatments
on the other hand carry the risk of overestimating
methylation levels due to detection of non-converted
cytosine.
High levels of DNA degradation decrease the number
of DNA molecules, which are eﬀectively available for
PCR ampliﬁcation. Hence, common PCR ampliﬁcation
strategies rely on using large amounts of bisulﬁte-treated
DNA. Diﬀerent ampliﬁcation protocols recommend
the use of 50–500ng of bisulﬁte-treated DNA (2).
These strategies are not feasible for most research based
on human samples, because DNA quantity usually is
limited. In order to maximize the number of tests that
can be run from one sample, it is desirable to minimize
the amount of DNA used per test. Recently, new assay
formats and miniaturization has enabled routine ampliﬁ-
cation from as little as 10ng bisulﬁte-treated DNA (5,6).
Ten nanograms of DNA equal approximately 6600 copies
of genomic DNA. With more than 90% DNA degrada-
tion during bisulﬁte treatment, only relatively few
molecules are left for PCR ampliﬁcation. The number of
available molecules is also inﬂuenced by the length of
the target amplicon. Longer amplicons are less likely to
amplify, simply because the likelihood to ﬁnd a single
intact starting template decreases. This fact requires
special attention if the analysis of DNA methylation is
not restricted to a binary yes/no answer, but is required to
provide quantitative results. When only few molecules
are used as starting template statistical eﬀects during
the sampling procedure can have a dramatic eﬀect on the
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that a procedure for assessment of DNA quality in
advance will dramatically help planning and interpreting
quantitative methylation experiments.
Methods that allow a quality evaluation of bisulﬁte-
treated DNA are HPLC or gel-based assays. These assays
need vast amounts of DNA and consume most of the
product yielded by a single bisulﬁte conversion reaction.
To overcome current limitations, we developed a new
assay for quality control that can be performed with as
little as 30ng of bisulﬁte-treated DNA.
The assay concept is based on the idea that random
DNA fragmentation reduces the number of available
molecules for PCR ampliﬁcation, especially with increas-
ing amplicon length. This random fragmentation has
two main eﬀects. When no intact DNA fragments are
available for the targeted ampliﬁcation region, the PCR
reaction will obviously fail. Second, when the number
of available molecules is drastically reduced, to only
a few available molecules due to DNA fragmentation,
the results become similar to digital PCR (7). They are no
longer quantitative and show large variability when
measured repeatedly. The approach presented here takes
both of these eﬀects into account. We designed amplicons
of increasing length for a genomic region with known
methylation levels. Then we measured the ampliﬁcation
success and variance in the quantitative results. To enable
measurement of quantitation variance, a method with
high quantitation precision and low process variability
is needed. We recently introduced a new method for the
quantitative analysis of DNA methylation, which fulﬁlls
these requirements (6). The method uses base-speciﬁc
cleavage of single-stranded nucleic acids coupled with
MALDI-TOF MS detection. The assay allows quantita-
tive analysis of all CpG sites within a given target region
and is only limited in length by PCR success.
METHODS
Bisulfite treatment
Bisulﬁte treatment of genomic DNA was performed
with a commercial kit from Zymo Research Corporation
(Orange, CA) that combines bisulﬁte conversion and
DNA clean up. The kit follows a protocol from Paulin
et al. (1998) (4). Brieﬂy, in this protocol 2mg of genomic
DNA is denatured by the addition of 3M sodium
hydroxide and incubated for 15min at 378C. A 6.24M
urea/2M sodium meta-bisulﬁte (4M bisulﬁte) solution is
prepared and added with 10mM hydroquinone to the
denatured DNA. The corresponding ﬁnal concentrations
are 5.36M, 3.44M and 0.5mM respectively. This reaction
mix is repeatedly heated between 558C for 15min
and 958C for 30s in a PCR machine (MJ Tetrad) for
20 cycles. Finally a DNA puriﬁcation and cleaning
step is performed.
Gel-basedfragmentation analysis
Two micrograms of DNA was bisulﬁte-treated using the
EZ DNA Methylation kit (Zymo Research, Orange, CA)
and eluted in 10ml water. Ten microliters of the
bisulﬁte-treated DNA was loaded along with 5mlo f
loading dye on a 4–8% TBE PAGE pre-cast gel (Jule Inc.,
Milford, CT). Ten microliters of 100bp ladder (Roche
Applied Science, Indianapolis, IN) was loaded alongside
the DNA samples. Electrophoresis was performed using
Novex Mini-Cell (Invitrogen, Carlsbad, CA) at 170V for
50min. Prior to ﬂuorescence detection, the gel was stained
using SYBR Gold gel stain (Invitrogen, Carlsbad, CA)
for 30min on an agitator. Fluorescence detection was
performed using the TYPHOON 8600 (GE Healthcare,
Piscataway, NJ) and densitometry measurements were
calculated using the supplied Image Quant Software.
PCR and invitro transcription
The target regions were ampliﬁed using the primer pairs
described in Supplement Table 1. The PCR reactions
were carried out in a total volume of 5ml using 1pmol
of each primer, 40mM dNTP, 0.1U Hot Star Taq DNA
polymerase (Qiagen), 1.5mM MgCl2 and buﬀer supplied
with the enzyme (ﬁnal concentration 1x). The reaction mix
was pre-activated for 15min at 958C. The reactions were
ampliﬁed in 45 cycles at 958C for 20s, 628C for 30s and
728C for 30s followed by 728C for 3min. Unincorporated
dNTPs were dephosphorylated by adding 1.7mlH 2O
and 0.3U Shrimp Alkaline Phosphatase (SEQUENOM,
San Diego). The reaction was incubated at 378C for
20min and SAP was then heat-inactivated for 10min
at 858C.
Typically, two microliters of the PCR reaction were
directly used as template in a 6.5ml transcription reaction.
Twenty units of T7 R&DNA polymerase (Epicentre,
Madison, WI) were used to incorporate either dCTP
or dTTP in the transcripts. Ribonucleotides were used
at 1mM and the dNTP substrate at 2.5mM; other
components in the reaction were as recommended by the
supplier. In the same step of the in vitro transcription
RNase A (SEQUENOM, San Diego) was added to cleave
the in vitro transcript. The mixture was then further
diluted with H2O to a ﬁnal volume of 27ml. Conditioning
of the phosphate backbone prior to MALDI-TOF
MS was achieved by the addition of 6mg CLEAN
Resin (SEQUENOM Inc., San Diego, CA). Further
experimental details have been described elsewhere (8).
Mass spectrometry measurements
Fifteen nanoliters of the cleavage reactions were
robotically dispensed onto silicon chips preloaded with
matrix (SpectroCHIP; SEQUENOM Inc., San Diego,
CA). Mass spectra were collected using a MassARRAY
mass spectrometer (Bruker–SEQUENOM). Spectra were
analyzed using proprietary peak picking and spectra
interpretation tools.
Statistical analysis
All statistical simulations and calculations were
carried out using the ‘R’ software package for statistical
computing (9). For the calculation of 95% conﬁdence
intervals of the binomial distribution we used the
‘binconf’ function, which is part of the Hmisc package.
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The main idea of this study is to evaluate the hypothesis
that the number of template DNA molecules, which
are available for PCR ampliﬁcation, are a determining
factor not only for the success of the reaction but,
more importantly, for determining the precision of
quantitative applications.
To evaluate the eﬀect of DNA degradation on
the quantitative and qualitative analysis of DNA methyla-
tion, we ﬁrst characterized the fragmentation pattern
of bisulﬁte-treated DNA. Next, we looked into the
relationship between available template molecules and
variation of methylation ratios caused by sampling error.
Based on these considerations we evaluated the feasibility
of a quality control assay that can be used to predict
DNA quality and verify its applicability for the intended
experiments. Finally we compared the experimental
data with the statistical models used for the evaluation
of sampling error.
In this study, all calculations are based on the DNA
amounts used in our current ampliﬁcation protocol.
We used 1mg of genomic DNA for bisulﬁte treatment
and eluted the treated DNA in 100mlH 2O. Then 1mlo f
this elution is used in each PCR. This amount roughly
equals 6000 DNA copies (10ng DNA 6600) and
denotes the maximum number of molecules available
for ampliﬁcation assuming that no DNA degradation
occurs. Unfortunately, DNA degradation is likely to
occur and hence the number of available molecules
can range between zero (complete degradation) and
 6000 (no degradation).
Stability of themethod
A prerequisite for the reliable measurement of the
variance of quantitative methylation analysis is a stable
method of detection that does not introduce any varia-
bility itself. To evaluate the variability of our method,
we dissected the entire process into four steps and
analyzed process-speciﬁc variability for each step. One
DNA was used in 16 replicated bisulﬁte treatments.
Then an aliquot of each bisulﬁte treatment was pooled
together and used for 16 individual PCR reactions.
Again an aliquot from those PCR reactions was pooled
and used for 16 individual base-speciﬁc cleavage reactions.
Finally aliquots of the cleavage reactions were pooled and
dispensed on 16 elements of a miniaturized array of matrix
spots. Figure 1 illustrates the process speciﬁc variability
in a box plot. The results for each of the four tested
conditions are summarized in an individual box plot.
The analysis of all steps reveals that process variability
of the base-speciﬁc cleavage reaction and the instrument
measurements are minimal compared to PCR and
especially bisulﬁte treatment (Figure 1).
Simulation
To evaluate theoretical limitations of quantitative
methylation analysis we applied the following assump-
tions to the model system.
Let N be the number of DNA molecules available for
PCR ampliﬁcation in the reaction. Suppose they have
been drawn randomly and independently from the whole
population of DNA molecules. Let p be the proportion of
molecules in the whole population which are methylated.
The number of methylated molecules in the reaction is
a random variable X which follows a binomial distribution
with parameters N and p.I fNp and N(1 p) are
both large enough, then X is approximately normally
distributed with expected value Np and variance Np(1 p)
with the appropriate continuity correction.
Consequently the probability of observing a methyla-
tion ratio in an interval is the cumulative probability from
the lower limit to the upper limit.
Figure 2A shows the cumulative probability for two
scenarios at 1% interval. The red bars are based on the
assumption that 3000 molecules (50% degradation)
are available for ampliﬁcation. The blue bars are calcula-
tions for 300 available molecules (95% degradation).
We calculated ﬁve scenarios of diﬀerent methylation ratios
in the starting template between 10 and 90% (10, 25, 50,
75 and 90%). As expected the probability distribution
maximizes around the population mean. We were also
interested in which range most (95%) of the values for
each methylation ratio would be located. The graph
reveals that for 50% methylation most values are located
between 48 and 52% when starting with 6000 molecules.
The range is dramatically larger with only 300 molecules
and ranges from 43 to 57% methylation. To evaluate the
Figure 1. Box plot graphic depicting the variability of repeated
measurements for each step in the process (Step 1: bisulphite treatment;
Step 2: PCR; Step 3: MassCLEAVE; Step 4: MALDI-TOF MS
analysis). Boxes are centered on the median and range from the lower
to the upper quartile. Whiskers indicate the interquartile range.
Red whiskers indicate the standard deviation from the mean. Bisulﬁte
treatment and PCR can be identiﬁed as the greatest source of process
variability. The post-PCR processing (MassCLEAVE) and, in parti-
cular, the MALDI analysis show high precision in repeated
measurements.
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of available DNA molecules, we calculated the 95%
conﬁdence interval for the binomial distribution as a
function of available fragments for three diﬀerent
scenarios (10, 25 and 50% methylation) (Figure 2B).
The ﬁgure illustrates the strong correlation with the
number of available fragments and indicates the drama-
tically increasing range of methylation ratios when the
number of available fragments falls below 100–200.
Gel-basedassessment of DNA fragmentation
To estimate the level of DNA fragmentation we
performed a densitometry-based analysis of original
genomic DNA and DNA treated with three diﬀerent
bisulﬁte conversion protocols (A—incubation at 508C;
B—incubation at 658C; C—incubation at 808C for 16h).
To achieve the necessary sensitivity we used 2mg bisulﬁte-
treated DNA on a 4–8% gradient PAGE gel, and stained
with SYBR GOLD (Figure 3) (10). We also performed
a densitometry calculation for the DNA size intervals
of 100bp. The interval for fragments below 100bp could
not be calculated accurately, because fragments below
75bp are lost during the DNA cleanup.
For each of the four conditions 2mg of DNA were
transferred onto the gel. The fragmented portions of the
genomic DNA appear as a high intensity band around
2600bp, while the high molecular weight genomic DNA
is unable to enter the gel (supplementary Figure 1).
During bisulﬁte treatment, the genomic DNA is
degraded, which results in a loss of the high intensity
band at 2600bp and additional fragmentation of the
previously unfragmented DNA. Consequently the signal
intensities are distributed over a larger area and no single
high intensity band is observed. The three diﬀerent
bisulﬁte protocols show varying fragment sizes.
The resulting distribution of signal intensities is variable
Figure 2. Panel (A) shows the probability distributions for observed methylation ratios based on the binomial distribution and diﬀerent amounts
of starting molecules. Shown are examples for 10, 25, 50 75 and 90% methylated molecules in the starting template. With a sample size of
3000 molecules, 95% of all randomly sampled probes will contain between 48 and 52% methylated DNA when the DNA sample contains
50% methylated DNA (red colored distribution). However, when the DNA sample contains only 300 molecules, this range is expanded from
43 to 57% (blue colored distribution). Panel (B) shows the 95% conﬁdence intervals for sampling-means as a function of the number of the sampled
molecules. Shown are results for 10 (blue), 25 (red) and 50% (black) methylated molecules in the starting template.
Figure 3. Gradient PAGE gel with CYBR Gold staining showing the
DNA fragmentation of untreated genomic DNA (left) and after
bisulﬁte treatment at varying temperatures (from left to right: 50, 70
and 808C). The ﬁgure indicates that an increase of the incubation
temperature during bisulﬁte treatment results in increased DNA
fragmentation.
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of DNA fragments is found to be41500bp in length for
condition A and around 200bp in length for condition C.
These results conﬁrm that higher incubation temperatures
introduce higher levels of DNA fragmentation.
With depurination being the most likely cause for
DNA fragmentation the position of strand breaks can be
assumed to be random. Thus higher DNA fragmentation
is more likely to disrupt the desired ampliﬁcation region
and hence eliminate its availability for PCR ampliﬁcation.
This also has implications for the targeted amplicon
length. When long amplicons are desired it is more likely
that a strand break will occur in-between the primer
binding sites and consequently less molecules are available
for ampliﬁcation. Shorter target regions are less likely
to have strand breaks and therefore are more likely to
be successfully ampliﬁed. Hence, short amplicons and
low fragmentation increase the probability of ampliﬁca-
tion success.
Consequently we can use an assay that utilizes
amplicons of diﬀerent length to estimate DNA fragmenta-
tion levels. In particular a more accurate result can
be given when employing a quantitative assay, because
it can utilize information about measurement variance,
rather than being limited to a binary yes/no answer.
QC assay
To evaluate the feasibility of variable length amplicons to
predict quality of bisulﬁte-treated DNA, we selected the
IGF2/H19 region as the ampliﬁcation target. Amplicon
design should ideally cover the region with multiple
amplicons increasing in length by small increments.
Unfortunately, ﬂexibility in primer design is constrained
by genomic DNA features. The primer binding sites have
to be free of any CpG sites and each amplicon should
be almost entirely covered by the next longer amplicon.
We also required identical hybridization behavior of the
diﬀerent primer sets to enable simultaneous ampliﬁcation
in a single microtiter plate. For the IGF2 region we were
able to design 6 amplicons, which were 176, 362, 477, 617,
795 and 960bp in length (Figure 4A). In the following we
will refer to this assay set as control assays.
All amplicons were tested in 16 repeats on DNA treated
with a single standard bisulﬁte conversion protocol.
We were able to obtain consistent ampliﬁcation for
176, 362, 477, 617, and sporadic ampliﬁcation for 765.
The longest amplicon failed to give any ampliﬁcation
results. This can either be attributed to bad primer design
or to the fact that the bisulﬁte-treated DNA does not
provide enough intact copies for PCR ampliﬁcation.
Consequently, we focused on the ﬁrst four amplicons
(176, 362, 477 and 617bp) for the quality control assay.
As a next step we induced increased fragmentation
of DNA by increasing incubation temperatures (50, 65, 80,
958C) during bisulﬁte treatment (Figure 4B).
We then applied the quality control assay to evaluate its
ability to asses DNA quality. For each condition bisulﬁte
treatment was done in triplicate and from each bisulﬁte-
treated DNA we performed duplicate PCR reactions.
To compare the quantitative results we selected 3CpG
sites which were enclosed in all amplicons. We analyzed
the generated mass spectra with regards to spectrum
quality and relative methylation for the selected three
CpG sites. In this setup 18 quantitative measurements
were obtained for each condition. We summed the number
of good quality measurements (deﬁned in the Method
section) as a ﬁrst marker for ampliﬁcation success and
obtained mean methylation levels and standard deviation
as a marker for sample bias.
The results show that incubation at 50 and 658C for 16h
yielded comparable results. Both show complete good
quality measurements up to an amplicon length of 477bp
and a decrease in good quality measurements for the
617bp amplicon. Standard deviation of repeated measure-
ments in both cases is around 5% and therefore within
instrument limitation. Incubation at 808C shows reduced
quality beginning at 362bp and incubation at 958C, results
in less than 50% good quality at 176bp. For 80 and 958C,
the obtained standard deviation of methylation ratios
are well above the expected 5% (from 40 to 45%).
When the individual values are closely examined we see
that methylation in these cases varies between 0 and 100%
(Figure 5). This behavior is predicted by the simulations
for very low numbers of available molecules. In the
extreme case we can assume that only one molecule is
available for ampliﬁcation. This one molecule is then
either methylated or non-methylated and therefore results
in large diﬀerences in observed methylation ratios.
The incubation at 808C exempliﬁes why measuring vari-
ance provides valuable information above the sole success
rates. In this case 15 out of 18 measurements were of good
quality suggesting that DNA quality is suﬃcient for the
analysis of DNA methylation. However, the quantitative
analysis reveals an ampliﬁcation behavior similar to digital
PCR (7). The observed methylation ratios cannot be
measured reproducibly and therefore show high variance.
In the next step we evaluated a second incubation
protocol. Instead of incubation for 16h at a constant
temperature, the temperature is cycled between the
Figure 4. Panel (A) shows a schematic representation of the diﬀerent
PCR amplicons and their genomic context on chromosome 11. All PCR
amplicons share a subset of CpG sites (indicated as red stripes), which
were used for comparison of methylation ratios. Panel (B) shows an
agarose gel for the six ampliﬁcation products of the IGF2 region.
Shown are PCR results for the six amplicons shown in panel (A) for
four diﬀerent bisulﬁte treatment incubation temperatures. The gel
picture conﬁrms that increasing incubation temperatures during bisulﬁte
treatment lead to a decrease in the obtainable ampliﬁcation length.
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step. The protocol comprises 20 cycles of 15min
at incubation temperature and 30s at 958C resulting
in a total incubation time of 5½h (Figure 5C and D).
The data was analyzed according to the scheme
described above. Incubation at 50 and 658C results in
stable measurements up to 477bp amplicon length,
which is comparable to constant 16h incubation.
For 808C cycled incubation amplicons of length 176 and
362bp are of acceptable quality in contrast to the ﬁrst
808C protocol where large variance was observed even
in the short amplicons.
Incomplete bisulﬁte conversion was not observed under
any of the used bisulﬁte treatment incubation protocols.
The results suggest that cycled incubation can improve
the quality of bisulﬁte-treated DNA. The results further
indicate the assay to be a good marker for DNA quality.
Extrapolation to multiple amplicons
In the next step we wanted to evaluate if results from this
limited region can be generalized to the remaining
genomic regions. We used a total of 39 amplicons from
diﬀerent regions in the genome with varying ampliﬁcation
lengths from 200 to 650bp. Having demonstrated the
general feasibility of using increasing temperatures to
create diﬀerentially fragmented DNA we used three
instead of four temperatures for the fragmentation of
DNA (A—508C 16h; B—708C 16h; C—908C 16h).
Each bisulﬁte treatment was done in triplicate.
Each sample was evaluated with our quality control
assay and across all samples. Finally, the results were
correlated to evaluate their concordance. In order to
compare diﬀerent length amplicons with diﬀerent number
of measurable CpG site we analyzed the ampliﬁcation
success of each amplicon by calculating the ratio of
successful quantitative CpG measurements to all possible
CpG measurements.
The quality control assay predicts good quality
ampliﬁcation up to 600bp for condition A. Condition B
shows successful ampliﬁcation at 477bp, but with an
increased methylation variance suggesting that this
ampliﬁcation length is borderline. For condition C
ampliﬁcation success is dramatically reduced at 176bp
suggesting impaired ampliﬁcation of the shortest targets in
the test set (Figure 6A and B).
The results from the ampliﬁcation of 39 selected
target regions conﬁrm the prediction of the quality
control assay. Condition A shows good ampliﬁcation
results throughout the entire range of amplicon
lengths. For condition B quality results start declining
Figure 5. Bar graphs showing the number of high quality mass spectra for each amplicon length (two panels on the left). The panels on the right side
show the corresponding standard deviations of the quantitative measurements. The bar graphs show results for diﬀerent bisulﬁte incubation
protocols. The results from 16h incubation at constant temperature are shown in the upper two panels and results from a cycled incubation protocol
are shown in the lower two panels. A total of 18 reactions were performed for each amplicon. Cycled incubation and lower incubation temperatures
result in higher ampliﬁcation success for longer amplicons and lower standard deviations on the determination of methylation ratios.
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quality from the shortest amplicons around 250bp
(Figure 6C and D).
These results verify the ability of the presented quality
control assay to predict the quality of bisulﬁte-treated
DNA and to estimate the chances for ampliﬁcation
success.
DISCUSSION
Most methods for the analysis of DNA methylation
are based on bisulﬁte treatment of genomic DNA.
The success of all methods have to rely on the quality of
the DNA after bisulﬁte treatment. Despite large interest
in DNA methylation no method for assessing the quality
of bisulﬁte-treated DNA has been shown to be generally
applicable. Gel-based methods require around 2mgo f
DNA. UV or ﬂuorescence-based methods allow for
quantiﬁcation, but do not yield information about
DNA fragmentation. Here we present a new approach
for quality control of bisulﬁte-treated DNA. The assay
comprises four amplicons of increasing length which are
located in the IGF2/H19 region. It combines measuring
the ampliﬁcation success with calculating the variance
of methylation ratios to give a realistic estimate of
DNA quality.
We suggest practical implementation of the assay
in a stepwise fashion. First, the control amplicon closest
to the maximum length of the desired study amplicons
is evaluated in triplicate. If the quality is good the study
can be performed, otherwise the remaining shorter
amplicons should be tested to evaluate the length
limitations for this bisulﬁte-treated DNA. Conclusively,
either a subset of the study amplicons can be run, or the
bisulﬁte treatment needs to be repeated. This approach
requires 30–120ng of DNA, depending on the desired
information level. Using a bisulﬁte protocol, which uses
1mg DNA, enough bisulﬁte-treated DNA is left for
88 to 97 PCR reactions.
In this study we used diﬀerent incubation temperatures
during bisulﬁte treatment to generate diﬀerently fragmen-
ted DNAs in a controlled environment. These increasing
fragmentation levels are used to demonstrate the feasibility
of our model to determine DNA quality and predict
Figure 6. Correlation between the results obtained from the quality control assays and PCR success from additional genomic targets of varying
length. The bar graphs in panel (A) and (B) show the results from the quality control assays similar to Figure 5. The QC assay indicates that
incubation at 908C limits ampliﬁcation to only short amplicons (5300bp), whereas incubation at 708C results in decreased ampliﬁcation success
for amplicons around 500bp in length. Panel (C) and (D) show results for further 39 PCR amplicons of diﬀerent genomic regions ranging in length
from 200 to 700bp. Panel (c) shows the percentage of successful quantitative measurements in relationship to the amplicon length. Panel (D) shows
a gel picture of the PCR results. Both conﬁrm the results predicted from the use of the QC assay (panel a and b).
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are run at 508C and the relevance of the model can be
questioned. In fact, temperature is only one of the many
aspects that inﬂuence DNA quality. In general the bisulﬁte
treatment procedure has always been a source of great
variability. Each of the reaction parameters like quality of
the template DNA, pH, incubation time and temperature,
the concentration of urea or hydroquinone can critically
inﬂuence DNA quality during the reaction. Most labora-
tories have either home-brew protocols, which have evolved
over years or rely on commercially available kits. Our
laboratory greatly beneﬁted from the availability of
commercial kits, but we still see occasional assay failures.
We showed that the number of molecules available
for PCR ampliﬁcation is critical for accurate characteriza-
tion of methylation ratios. This number of available
template molecules is determined by the amount of
genomic DNA, fragmentation level of bisulﬁte-treated
DNA and amplicon length. When few molecules are
present, the reaction can still be performed successfully,
but the sampling error has a devastating eﬀect on the
conﬁdence level of the quantitative results. Hence, it is
important to know in advance which amplicon lengths
can be accurately analyzed, highlighting the importance
of quality control. Our assays use only 30–120ng
of the bisulﬁte-treated DNA and allow using the
remaining DNA in quantitative studies.
We think the assay will be of special interest for
three applications: (1) The QC assay is used to estimate
the quality of sample DNA after bisulﬁte treatment.
In a study where the desired amplicon lengths are known,
the assay can indicate whether or not these amplicon
can be analyzed. (2) Improve bisulﬁte treatment proce-
dures. In the presented work we found shorter cycled
incubation superior to long continuous incubation. Many
other parameters of the bisulﬁte treatment can be
optimized further, for example, using a design of
experiment (DOE) approach, to assure best possible
DNA quality. (3) When standardized bisulﬁte procedures
are already implemented and their performance charac-
teristics are known, this assay can be used to help
researchers achieve uniform quality standards. It is
noteworthy that the described assay can also be imple-
mented on platforms other than MALDI TOF MS
(e.g. Pyrosequencing), as long as the precision in
quantitative measurement is suﬃcient.
We feel the implementation of the presented quality
control assay will greatly assist in developing new
and more robust bisulﬁte conversion protocols and help
to better understand quantitative DNA methylation
results.
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